The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: Results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial Academic Article uri icon

Overview

MeSH Major

  • Anti-Arrhythmia Agents
  • Atrial Fibrillation
  • Calcium Channel Blockers
  • Imidazoles
  • Imidazolidines
  • Piperazines
  • Ventricular Dysfunction, Left

abstract

  • Azimilide was safe and effective AF therapy in patients with depressed LV function after an MI.

publication date

  • April 7, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jacc.2003.10.057

PubMed ID

  • 15063432

Additional Document Info

start page

  • 1211

end page

  • 6

volume

  • 43

number

  • 7